Recallr: Genzyme Corporation Recalls Thymoglobulin
Genzyme Corporation , Genzyme Europe B.V., and Genzyme Polyclonals, S.A.S. have initiated recall of Thymoglobulin finished product lots: C7014C01, C7008C01, and TH175-05. This recall was initiated when Thymoglobulin lot C7014C01 failed a periodic stability test based upon appearance of the reconstituted product.
tag: FDA Recall, Medical Recalls, Thymoglobulin Recall, Genzyme Corporation Recall, Anti-thymocyte Globulin,
No comments:
Post a Comment